Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Clinical Outcome
39 results:

  • 1. Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.
    Li Y; Shen Z; Chai Z; Zhan Y; Zhang Y; Liu Z; Liu Y; Li Z; Lin M; Zhang Z; Liu W; Guan S; Zhang J; Qian J; Ding Y; Li G; Fang Y; Deng H
    Gut; 2023 Nov; 72(12):2307-2320. PubMed ID: 37507218
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.
    Tang Y; Thiess L; Weiler SME; Tóth M; Rose F; Merker S; Ruppert T; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2023 Jun; 21(1):162. PubMed ID: 37381005
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Depletion of Fibroblast Growth Factor 12 Restrains the Viability, Stemness, and Motility of colorectal cancer.
    Gao X; Liao Z; Su R; Zheng D; Huang G; Huang Z; Cheng X
    Biomed Res Int; 2022; 2022():9948461. PubMed ID: 35860801
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated Analysis of DNA Repair Genes Identifies SLC6A1 as a New Marker for the clinical outcome of Patients with colorectal cancer.
    Wang QQ; Wei Y; Luo LP; Li X; Jiang WJ
    Dis Markers; 2022; 2022():4952812. PubMed ID: 35251372
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification and functional analysis of lncRNAs and mRNAs between tumorigenesis and metastasis in CRC.
    Liu H; Tian Y; Li J; Zhang G; Liu Q; Yang M; Yue L; Cao Q; Zhang G; Cheng Y; Kong N; Fang L; Li S; Sun Q
    Aging (Albany NY); 2021 Dec; 13(24):25859-25885. PubMed ID: 34954693
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. clinical Benefit of Therapeutic Drug Monitoring in colorectal cancer Patients Who Received Fluorouracil-Based Chemotherapy.
    Zhou X; Chang Y; Qian J; Shen C; Han J; Zhao H; Chang R
    Med Sci Monit; 2021 Jul; 27():e929474. PubMed ID: 34330885
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Correlation of PRL3 expression with colorectal cancer progression.
    Leiphrakpam PD; Lazenby AJ; Smith LM; Brattain MG; Black JD; Wang J; Are C
    J Surg Oncol; 2021 Jan; 123(1):42-51. PubMed ID: 33179291
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
    Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
    Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Role of miRNA-Regulated cancer Stem Cells in the Pathogenesis of Human Malignancies.
    Khan AQ; Ahmed EI; Elareer NR; Junejo K; Steinhoff M; Uddin S
    Cells; 2019 Aug; 8(8):. PubMed ID: 31530793
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑ mesenchymal transition via the akt/GSK‑3β/Snail signaling pathway.
    Yuan L; Zhou M; Huang D; Wasan HS; Zhang K; Sun L; Huang H; Ma S; Shen M; Ruan S
    Mol Med Rep; 2019 Sep; 20(3):2783-2795. PubMed ID: 31524255
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating akt signaling pathway.
    Yu J; Liu M; Liu H; Zhou L
    Mol Cell Biochem; 2019 Jul; 457(1-2):191-199. PubMed ID: 31069596
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of Patient Gender and race and Physician Communication on colorectal cancer Diagnostic Visits in Primary Care.
    Rogers HL; Dumenci L; Epstein RM; Siminoff LA
    J Womens Health (Larchmt); 2019 May; 28(5):612-620. PubMed ID: 30489201
    [No Abstract]    [Full Text] [Related]  

  • 13. Efficacy, Safety, and Cost of Therapy of the Traditional Chinese Medicine, Catalpol, in Patients Following Surgical Resection for Locally Advanced Colon cancer.
    Fei B; Dai W; Zhao S
    Med Sci Monit; 2018 May; 24():3184-3192. PubMed ID: 29763415
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Consensus on structured training curriculum for transanal total mesorectal excision (TaTME).
    Francis N; Penna M; Mackenzie H; Carter F; Hompes R;
    Surg Endosc; 2017 Jul; 31(7):2711-2719. PubMed ID: 28462478
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.
    Zhang X; Shimodaira H; Soeda H; Komine K; Takahashi H; Ouchi K; Inoue M; Takahashi M; Takahashi S; Ishioka C
    Int J Clin Oncol; 2016 Dec; 21(6):1091-1101. PubMed ID: 27435270
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. NDRG4 stratifies the prognostic value of body mass index in colorectal cancer.
    Zheng J; Li Y; Zhu S; Li J; Zhao Q; Ji G; Wang W; Chu D
    Oncotarget; 2016 Jan; 7(2):1311-22. PubMed ID: 26515606
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Opposing prognostic roles of nuclear and cytoplasmic racGAP1 expression in colorectal cancer patients.
    Yeh CM; Sung WW; Lai HW; Hsieh MJ; Yen HH; Su TC; Chang WH; Chen CY; Ko JL; Chen CJ
    Hum Pathol; 2016 Jan; 47(1):45-51. PubMed ID: 26508373
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro.
    Sriraman SK; Geraldo V; Luther E; Degterev A; Torchilin V
    J Control Release; 2015 Dec; 220(Pt A):160-168. PubMed ID: 26497930
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer.
    Kaur A; Elzagheid A; Birkman EM; Avoranta T; Kytölä V; Korkeila E; Syrjänen K; Westermarck J; Sundström J
    Cancer Med; 2015 Dec; 4(12):1798-808. PubMed ID: 26377365
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs).
    Prasetyanti PR; Capone E; Barcaroli D; D'Agostino D; Volpe S; Benfante A; van Hooff S; Iacobelli V; Rossi C; Iacobelli S; Medema JP; De Laurenzi V; Sala G
    Oncotarget; 2015 Jul; 6(19):16902-11. PubMed ID: 26160848
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.